Arnold L. E. et al. (2006)
Journal of the American Academy of Child and Adolescent Psychiatry
45(10), pp. 1196-1205
Arnold L. E. et al. (2003)
Journal of the American Academy of Child and Adolescent Psychiatry
42(12), pp. 1443-1450
Arnold L. E. et al. (2012)
Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.
Journal of Child and Adolescent Psychopharmacology
22(3), pp. 198-205.
Arnold L. E. et al. (2012)
Journal of the American Academy of Child and Adolescent Psychiatry
51(11), pp. 1173-1184.
Carroll D. et al. (2014)
Child and Adolescent Psychiatric Clinics of North America
January, 23(1), pp. 57-72.
Einfeld S. L. , Aman M. G. (1995)
Issues in the taxonomy of psychopathology in mental retardation
Journal of Autism and Developmental Disorders
25(2), pp. 143-167
Farmer C. A. , Aman M. G. (2011)
Aripiprazole for the treatment of irritability associated with autism.
Expert Opinion on Pharmacotherapy
12(4), pp. 635-640
Grondhuis S. , Aman M. G. (2012)
Assessment of anxiety in children and adolescents with autism spectrum disorders.
Research in Autism Spectrum Disorders
October, 6(4), pp. 1345-1365.
Handen B. L. et al. (2015)
Journal of the American Academy of Child and Adolescent Psychiatry
November, 54(11), pp. 905-915.
Hellings J. A. et al. (2015)
Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability.
Journal of Child and Adolescent Psychopharmacology
25(2), pp. 150–159.
Hollway J. A. , Aman M. G. (2011)
Sleep correlates of pervasive developmental disorders: A review of the literature.
Research in Developmental Disabilities
32(5), pp. 1399-1421.
Karabekiroglu K. , Aman M. G. (2008)
Validity of the Aberrant Behavior Checklist in a clinical sample of toddlers.
Child Psychiatry and Human Development
Lecavalier L. et al. (2014)
Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder.
Journal of Autism and Developmental Disorders
May, 44(5), pp. 1128-1143.